BIMI International Medical Inc (BIMI)
1.075
-0.06
(-4.87%)
USD |
NASDAQ |
May 24, 16:00
1.075
0.00 (0.00%)
After-Hours: 17:06
BIMI International Medical Enterprise Value: 17.56M for May 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 23, 2024 | 17.56M |
May 22, 2024 | 18.54M |
May 21, 2024 | 18.82M |
May 20, 2024 | 20.85M |
May 17, 2024 | 19.38M |
May 16, 2024 | 17.84M |
May 15, 2024 | 17.14M |
May 14, 2024 | 17.42M |
May 13, 2024 | 16.86M |
May 10, 2024 | 16.58M |
May 09, 2024 | 17.42M |
May 08, 2024 | 17.49M |
May 07, 2024 | 17.28M |
May 06, 2024 | 17.84M |
May 03, 2024 | 17.14M |
May 02, 2024 | 16.30M |
May 01, 2024 | 18.12M |
April 30, 2024 | 18.40M |
April 29, 2024 | 18.12M |
April 26, 2024 | 18.96M |
April 25, 2024 | 18.40M |
April 24, 2024 | 18.68M |
April 23, 2024 | 20.22M |
April 22, 2024 | 17.42M |
April 19, 2024 | 19.66M |
Date | Value |
---|---|
April 18, 2024 | 20.50M |
April 17, 2024 | 21.51M |
April 16, 2024 | 24.00M |
April 15, 2024 | 20.08M |
April 12, 2024 | 16.30M |
April 11, 2024 | 17.56M |
April 10, 2024 | 19.52M |
April 09, 2024 | 20.50M |
April 08, 2024 | 20.64M |
April 05, 2024 | 23.44M |
April 04, 2024 | 23.57M |
April 03, 2024 | 22.74M |
April 02, 2024 | 22.32M |
April 01, 2024 | 24.28M |
March 28, 2024 | 25.26M |
March 27, 2024 | 27.21M |
March 26, 2024 | 29.46M |
March 25, 2024 | 27.64M |
March 22, 2024 | 23.86M |
March 21, 2024 | 27.50M |
March 20, 2024 | 32.69M |
March 19, 2024 | 37.17M |
March 18, 2024 | 39.55M |
March 15, 2024 | 41.09M |
March 14, 2024 | 37.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.166M
Minimum
Mar 30 2023
87.11M
Maximum
Oct 14 2019
23.33M
Average
22.84M
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
Net Income (Quarterly) | -3.129M |
Revenue (Quarterly) | 2.523M |
Total Expenses (Quarterly) | 5.673M |
EPS Diluted (Quarterly) | -0.51 |
Gross Profit Margin (Quarterly) | 4.56% |
Profit Margin (Quarterly) | -124.0% |
Earnings Yield | -275.4% |
Normalized Earnings Yield | -143.42 |